375 related articles for article (PubMed ID: 19698808)
1. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.
Biellik R; Levin C; Mugisha E; LaMontagne DS; Bingham A; Kaipilyawar S; Gandhi S
Vaccine; 2009 Oct; 27(44):6203-9. PubMed ID: 19698808
[TBL] [Abstract][Full Text] [Related]
2. Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings.
Bingham A; Drake JK; LaMontagne DS
Arch Pediatr Adolesc Med; 2009 May; 163(5):455-61. PubMed ID: 19414692
[TBL] [Abstract][Full Text] [Related]
3. An assessment of the readiness for introduction of the HPV vaccine in Uganda.
Katahoire RA; Jitta J; Kivumbi G; Murokora D; Arube WJ; Siu G; Arinaitwe L; Bingham A; Mugisha E; Tsu V; LaMontagne DS
Afr J Reprod Health; 2008 Dec; 12(3):159-72. PubMed ID: 19435020
[TBL] [Abstract][Full Text] [Related]
4. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
5. Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.
Andrus JK; Sherris J; Fitzsimmons JW; Kane MA; Aguado MT
Vaccine; 2008 Aug; 26 Suppl 10():K87-92. PubMed ID: 18847561
[TBL] [Abstract][Full Text] [Related]
6. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
[TBL] [Abstract][Full Text] [Related]
7. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam.
Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D
Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609
[TBL] [Abstract][Full Text] [Related]
8. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs.
Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M
Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296
[TBL] [Abstract][Full Text] [Related]
9. Latin America. Price is the main barrier to wider use of papillomavirus vaccine.
Kaiser J
Science; 2008 May; 320(5878):860. PubMed ID: 18487164
[No Abstract] [Full Text] [Related]
10. Human papillomavirus vaccine introduction in Vietnam: formative research findings.
Nghi NQ; Lamontagne DS; Bingham A; Rafiq M; Mai le TP; Lien NT; Khanh NC; Hong DT; Huyen DT; Tho NT; Hien NT
Sex Health; 2010 Sep; 7(3):262-70. PubMed ID: 20719213
[TBL] [Abstract][Full Text] [Related]
11. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries.
LaMontagne DS; Barge S; Le NT; Mugisha E; Penny ME; Gandhi S; Janmohamed A; Kumakech E; Mosqueira NR; Nguyen NQ; Paul P; Tang Y; Minh TH; Uttekar BP; Jumaan AO
Bull World Health Organ; 2011 Nov; 89(11):821-830B. PubMed ID: 22084528
[TBL] [Abstract][Full Text] [Related]
13. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.
Kim JJ; Kobus KE; Diaz M; O'Shea M; Van Minh H; Goldie SJ
Vaccine; 2008 Jul; 26(32):4015-24. PubMed ID: 18602731
[TBL] [Abstract][Full Text] [Related]
14. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
[TBL] [Abstract][Full Text] [Related]
16. Implementation of the Australian HPV vaccination program for adult women: qualitative key informant interviews.
Leask J; Jackson C; Trevena L; McCaffery K; Brotherton J
Vaccine; 2009 Sep; 27(40):5505-12. PubMed ID: 19619501
[TBL] [Abstract][Full Text] [Related]
17. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
Hessel L
Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries.
Colantonio L; Gómez JA; Demarteau N; Standaert B; Pichón-Rivière A; Augustovski F
Vaccine; 2009 Sep; 27(40):5519-29. PubMed ID: 19616499
[TBL] [Abstract][Full Text] [Related]
19. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
Thomas TL
Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted.
Franco EL
BMJ; 2007 Aug; 335(7616):378-9. PubMed ID: 17717367
[No Abstract] [Full Text] [Related]
[Next] [New Search]
